Abstract: The present invention provides Tek antagonists and methods of inhibiting angiogenesis in a mammal by administering Tek antagonists. The methods are particularly useful in treating diseases or conditions mediated by angiogenesis, such as solid tumors and diseases or conditions characterized by ocular neovascularization.
Type:
Grant
Filed:
February 3, 2003
Date of Patent:
June 27, 2006
Assignee:
Immunex Corporation
Inventors:
Douglas P. Cerretti, Luis G. Borges, William C. Fanslow, III